Selecting a Treatment Regimen
Figure 2. Treatment Algorithm—The Chronic Disease
Management Model for Primary Care of Patients
with Overweight and Obesity
a
a
is algorithm applies to the assessment of overweight and obesity and subsequent decisions based on that
assessment. Each step (designated by a box in the guideline) in this process is reviewed in the guideline
section and expanded upon in subsequent sections.
b
BMI cutpoint determined by the FDA and listed on the package inserts of FDA-approved obesity
medications.
BMI 25-29.9 (overweight)
or 30-34.9 (class I obese) or
35-39.9 (class II obese) or ≥40
(class III obese)
BMI 18.5-24.9
Measure weight and calculate
BMI annually or more
frequently
Advise to avoid weight gain;
address and treat other risk
factors
Follow-up and weight loss
maintenance
YES
NO
Intensive behavioral treatment;
reassess and address medical
or other contributory factors;
consider adding or re-evaluating
obesity pharmacotherapy, and/
or refer for to an experienced
bariatric surgeon
Weight loss ≥5% and sufficient
improvement in health targets
YES
Continue intensive medical
management of CVD risk factors and
obesity-related conditions; weight
management options
NO
NO
Diagnostic
Treatment
Patient encounter
Measure weight, height;
calculate BMI
